Literature DB >> 27897462

Capacity and readiness for quality improvement among home and community-based service providers.

Kathleen Abrahamson1, Jaclyn Myers1, Greg Arling1, Heather Davila2, Christine Mueller2, Brian Abery2, Yun Cai1.   

Abstract

The objective of this study was to explore home and community-based service (HCBS) providers' perspectives of organizational readiness for quality improvement (QI). Data were obtained from a survey of participants (N = 56) in a state-sponsored HCBS QI initiative. Quality improvement challenges included lack of time and resources, staff apprehension or resistance, resistance from consumers and families, and project sustainability. Support from leadership was viewed as an important factor in participating organizations' decision to engage in QI. Internal resources available to support QI varied widely between participating organizations, with differences observed between smaller and larger agencies, as well as between provider types and populations served.

Entities:  

Keywords:  Home and community-based services; organizational readiness; quality; quality improvement; state policy

Mesh:

Year:  2016        PMID: 27897462     DOI: 10.1080/01621424.2016.1264343

Source DB:  PubMed          Journal:  Home Health Care Serv Q        ISSN: 0162-1424


  3 in total

1.  Preferences for home- and community-based long-term care services in Germany: a discrete choice experiment.

Authors:  T Lehnert; O H Günther; A Hajek; S G Riedel-Heller; H H König
Journal:  Eur J Health Econ       Date:  2018-04-06

2.  Readiness and Implementation of Quality Improvement Strategies Among Small- and Medium-Sized Primary Care Practices: an Observational Study.

Authors:  Tulay G Soylu; Alison E Cuellar; Debora G Goldberg; Anton J Kuzel
Journal:  J Gen Intern Med       Date:  2020-08-10       Impact factor: 5.128

3.  COVID-19 exposures and infection control among home care agencies.

Authors:  Theresa A Rowe; Mallika Patel; Rachel O'Conor; Sheila McMackin; Vicki Hoak; Lee A Lindquist
Journal:  Arch Gerontol Geriatr       Date:  2020-07-30       Impact factor: 3.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.